You have 9 free searches left this month | for more free features.

Limb-girdle

Showing 1 - 25 of 3,987

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Limb Girdle Muscular Dystrophy Trial in Columbus (SRP-9003)

Enrolling by invitation
  • Limb Girdle Muscular Dystrophy
  • SRP-9003
  • Columbus, Ohio
    Nationwide Children's Hospital
May 17, 2023

Limb-Girdle Muscular Dystrophy Type 2I (LGMD2I) Trial in Gainesville (BBP-418 (ribitol), Placebo)

Not yet recruiting
  • Limb-Girdle Muscular Dystrophy Type 2I (LGMD2I)
  • BBP-418 (ribitol)
  • Placebo
  • Gainesville, Florida
    University of Florida
Mar 16, 2023

Limb Girdle Muscular Dystrophy Trial in Columbus (SRP-6004)

Enrolling by invitation
  • Limb Girdle Muscular Dystrophy
  • SRP-6004
  • Columbus, Ohio
    Nationwide Children's Hospital
Jun 7, 2023

Trial Readiness and Endpoint Assessment in LGMD R1

Not yet recruiting
  • Calpain-3 Deficiency Limb Girdle Muscular Dystrophy Type 2A
  • +3 more
    • Richmond, Virginia
      Virginia Commonwealth University
    Jan 10, 2023

    Muscular Dystrophies, Limb-Girdle (GENETICALLY CONFIRMED) Trial in Charlotte

    Completed
    • Muscular Dystrophies, Limb-Girdle (GENETICALLY CONFIRMED)
      • Charlotte, North Carolina
        Carolinas Medical Center - Pediatrics
      Apr 20, 2022

      Motor Parameters in Patients With Limb Girdle Muscular Dystrophy

      Recruiting
      • Limb Girdle Muscular Dystrophies
        • Garche, France
          Laboratoire d'analyse du mouvement, Service d'exploration foncti
        May 2, 2022

        MRI-phenotyping of Patients With Pathogenic Anoctamin 5 Variants

        Recruiting
        • Limb Girdle Muscular Dystrophy
        • No intervention
        • Copenhagen, Denmark
          Nanna Scharff Poulsen
        Jan 17, 2023

        Limb-Girdle Muscular Dystrophy, Type 2E Trial in Columbus (SRP-9003)

        Active, not recruiting
        • Limb-Girdle Muscular Dystrophy, Type 2E
        • SRP-9003
        • Columbus, Ohio
          Nationwide Children's Hospital
        Sep 28, 2022

        Muscular Dystrophies, Spinal Muscular Atrophy, Duchenne Muscular Dystrophy Trial in Saint Paul (Abilitech Assist)

        Recruiting
        • Muscular Dystrophies
        • +6 more
        • Abilitech Assist
        • Saint Paul, Minnesota
          Gillette Children's
        Dec 1, 2022

        Dysferlinopathy, Miyoshi Myopathy, LGMDR2 Trial in Moscow

        Enrolling by invitation
        • Dysferlinopathy
        • +3 more
          • Moscow, Russian Federation
            Human Stem Cells Institute
          Jul 25, 2022

          Identification of Dominant Calpainopathies

          Enrolling by invitation
          • Calpain-3 Deficiency Limb Girdle Muscular Dystrophy Type 2A
          • retrospective study
          • Venice-Lido, VE, Italy
          • +1 more
          Jul 19, 2023

          Limb Girdle Muscular Dystrophy Type 2A and Type 2E

          Recruiting
          • Limb-Girdle Muscular Dystrophy Type 2A
          • Limb-Girdle Muscular Dystrophy, Type 2E
            • Columbus, Ohio
              Nationwide Children's Hospital
            Dec 6, 2021

            Limb Girdle Muscular Dystrophy, Limb-Girdle Muscular Dystrophy Type 2, LGMD2I Trial (LION-101 dose level 1, LION-101 dose level

            Not yet recruiting
            • Limb Girdle Muscular Dystrophy
            • +8 more
            • LION-101 dose level 1
            • +2 more
            • (no location specified)
            Feb 17, 2022

            LGMD2C Trial (ATA-200)

            Not yet recruiting
            • LGMD2C
            • ATA-200
            • (no location specified)
            Aug 1, 2023

            Patients With Limb-Girdle Muscular Dystrophy 2I

            Active, not recruiting
            • LGMD2I
              • Copenhagen, Denmark
              • +2 more
              Jan 4, 2022

              Patients With Limb Girdle Muscular Distrophy Type 2E

              Completed
              • LGMD2E
              • Exon 3 truncating mutation
              • Any other mutation in SGBC gene
              • Milano, Italy
                IRCCS Ca' Granda Ospedale Maggiore Policlinico
              Mar 29, 2022

              Limb-Girdle Muscular Dystrophy Type 2I in Norway

              Recruiting
              • Limb Girdle Muscular Dystrophy, Type 2I
              • +3 more
                • Tromsø, Norway
                  National Neuromuscular Centre, Norway
                Sep 9, 2021

                Limb-Girdle Muscular Dystrophy Trial in Worldwide (Deflazacort)

                Terminated
                • Limb-Girdle Muscular Dystrophy
                • Atlanta, Georgia
                • +17 more
                May 31, 2022

                Limb-girdle Muscular Dystrophy, Becker Muscular Dystrophy Trial in Chicago (Prednisone)

                Active, not recruiting
                • Limb-girdle Muscular Dystrophy
                • Becker Muscular Dystrophy
                • Chicago, Illinois
                  Northwestern University
                Jan 8, 2022

                Assess Exercise-induced Muscle Damage in Muscle Diseases

                Enrolling by invitation
                • Becker Muscular Dystrophy
                • +2 more
                  • Copenhagen, Denmark
                    Neuromuscular Research Unit, 3342
                  Dec 17, 2021

                  3 Year Follow up on ANO5 Patients

                  Active, not recruiting
                  • Neuromuscular Diseases
                  • Limb Girdle Muscular Dystrophy
                  • No intervention - pure observational study
                  • Copenhagen, Region Hovedstaden, Denmark
                    Copenhagen Neuromuscular Center
                  Jan 25, 2022

                  LGMD2E/R4, LGMD2D/R3, and LGMD2C/R5, = 4 Years of Age, Who Are

                  Recruiting
                  • Limb-girdle Muscular Dystrophy
                    • Phoenix, Arizona
                    • +14 more
                    Aug 23, 2022

                    LGMDR9 Trial in Copenhagen, Paris, Newcastle Upon Tyne (GNT0006, Day 0: Placebo, Day 0: GNT0006)

                    Recruiting
                    • LGMDR9
                    • GNT0006
                    • +4 more
                    • Copenhagen, Denmark
                    • +2 more
                    Oct 21, 2022

                    LGMD Trial (GenPHSat injection (Safety), GenPHSat injection (Efficacy), Muscle Biopsy (Safety))

                    Not yet recruiting
                    • LGMD
                    • GenPHSat injection (Safety)
                    • +2 more
                    • (no location specified)
                    Oct 20, 2022

                    LGMD2I Trial in Richmond (BBP-418)

                    Active, not recruiting
                    • LGMD2I
                    • Richmond, Virginia
                      Virginia Commonwealth University
                    Dec 17, 2021